Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

abatacept

abatacept
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Orencia IV POWDER FOR INJECTION, INTRAVENOUS 250 mg      
Orencia Subcutaneous SOLUTION, SUBCUTANEOUS 125 mg/mL      


Comments:

Orencia IV is restricted to use in Outpatient Medical Department. Defer inpatient orders to outpatient therapy whenever possible.

Orencia Subcutaneous is non-formulary, not stocked. Defer the dose until after discharge.


Reviewed: October 30, 2007 (Orencia IV) and December 13, 2011 (Orencia Subcutaneous)


Last updated: Dec. 28, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.